As a group, we are actively engaged in disseminating our latest research findings at a number of academic events and conferences. You can view some of our previous presentations at our ' Conference posters ' page under ' Publications '.
Upcoming events
There are no currently scheduled upcoming events. Please check back again for further updates.
Previous events
European Alliance of Associations for Rheumatology (EULAR) People with Arthritis and Rheumatism in Europe (PARE)
(Brussels, Belgium: 28 - 30 November 2024)
Martin Stevens made the following presentation at this event:
- Martin Stevens, The iPRePaRe study - introduction and application of outcome
This presentation will be made available here shortly.
American College of Rheumatology: Convergence 2024
(Washington DC, USA: 14 - 19 November 2024)
Group members made the following presentations at this event:
- Kate Timmins, Tim Hales and Gary Macfarlane. Childhood maltreatment increases risk of chronic widespread pain: counterfactual analysis of UK Biobank
- Lili Xu, Gareth Jones, Ovidiu Rotariu, Rosemary Hollick, and Gary Macfarlane. Predictors of Work Impairment and Absence Amongst People with Psoriatic Arthritis (PsA) - Evidence from the British Society for Rheumatology PsA Register (BSR-PsA) [poster presentation]
- Warren James, Corri Black, Neil Basu, Mark Little and Rosemary Hollick on behalf of the VOICES investigators. Sociodemographic Factors Associated with Clinic Non-attendance and Unscheduled Emergency Care Episodes in ANCA-associated Vasculitis [poster presentation]
Health Services Research UK Conference 2024
(Oxford, UK: 08 - 10 July 2024)
Dr Rosemary Hollick and Lynn Laidlaw delivered a presentation this event, incorporating results from the VOICES study, with recommendations for how we can improve care delivery for people with rare conditions such as systemic vasculitis.
You can watch a full video of the presentation below:
Occupational Health 2024
(Belfast, UK: 21 - 22 June 2024)
Cara Ghiglieri presented the following poster at this conference on behalf of the Making it Work™ - Scotland team:
- Cara Ghiglieri, R Stuart Anderson, Elaine Wainwright, Rosemary Hollick, Diane Lacaille, Gary Macfarlane and LaKrista Morton, Making it Work⢠- Scotland: Adapting a Canadian programme to support people working with musculoskeletal (MSK) conditions in the UK
British Pain Society Annual Scientific Meeting 2024
(Nottingham, UK: 4 - 6 June 2024)
Marcus Beasley presented the following poster at this event on behalf of the CHIPP team:
- Marcus Beasley, Elaine Wainwright and Gary Macfarlane on behalf of the CHIPP Investigators and Patient Research Partners, Population-Level Association between Physical Activity and High Impact Chronic Pain 10 Years Later
International Congress on Occupational Health (ICOH) 2024
(Marrakesh, Morrocco: 28 April - 03 May 2024)
QUICK Co-investigator Prof. Karen Walker-Bone presented the following poster at this event on behalf of the QUICK team:
- LaKrista Morton, Martin J Stevens, Elaine Wainwright, R Stuart Anderson, Ira Madan, Nicola Fear, Suzanne Verstappen, Paul McNamee, Anne Stagg, Nicola Goodson, Karen Walker-Bone, Rosemary J Hollick, Gary J Macfarlane, QUantifying the Impact of Chronic pain on worK (QUICK)
British Society for Rheumatology Annual Conference 2024
(Liverpool, UK: 24 - 26 April 2024)
Dr Rosemary Hollick and PhD student Alison Maciver made the following presentations at this event:
- Warren James, Avril Nicoll, Louise Locock, Lorrain Harper, Mark A Little, Neil Basu, Rosemary Hollick, Geographical variations in delivery of intravenous treatment for ANCA-associated vasculitis
In this poster presentation from the British Society for Rheumatology Annual Conference 2024, Dr Rosemary Hollick discusses access to intravenous (IV) immunosuppressant therapy for ANCA-associated vasculitis (AAV) across the UK and Ireland.
- Alison MacIver, Gary Macfarlane, Rosemary Hollick, Measuring social engagement in rheumatic and musculoskeletal diseases
In this poster presentation from the British Society for Rheumatology Annual Meeting 2023, Alison MacIver evaluates the existing measures of social engagement used in rheumatic and musculoskeletal disease (RMD) populations.
